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Abstract 1 
 2 
The Type VI secretion system (T6SS) is a multiprotein complex used by bacteria to 3 
deliver effectors into target cells. The T6SS comprises a bacteriophage-like contractile 4 
tail structure anchored to the cell envelope by a membrane complex constituted of the 5 
TssJ outer membrane lipoprotein and the TssL and TssM inner membrane proteins. 6 
TssJ establishes contact with the periplasmic domain of TssM whereas the 7 
transmembrane segments of TssM and its cytoplasmic domain interact with TssL. TssL 8 
protrudes in the cytoplasm but is anchored by a C-terminal transmembrane helix 9 
(TMH). Here, we show that TssL TMH dimerization is required for the stability of the 10 
protein and for T6SS function. Using the TOXCAT assay and point mutations of the 23 11 
residues of the TssL TMH we identified Thr194 and Trp199 as necessary for TssL TMH 12 
dimerization. NMR hydrogen-deuterium exchange experiments demonstrated the 13 
existence of a dimer with the presence of Trp185 and Trp199 at the interface. A 14 
structural model based on molecular dynamics simulations shows that TssL TMH dimer 15 
formation involves π-π  interactions resulting from the packing of the two Trp199 rings 16 
at the C-terminus and of the six aromatic rings of Tyr184, Trp185 and Trp188 at the N-17 
terminus of the TMH. 18 
 3 3 
 Introduction 1 
 2 
The Type VI secretion system (T6SS) is a molecular machine widely distributed in 3 
proteobacteria and responsible for the contact-dependent secretion of effector proteins into 4 
target cells [1,2]. Effectors delivered by this apparatus interfere with eukaryotic host cell 5 
physiology, or cause damages in bacterial cells [3-6]. The T6SS is therefore involved in 6 
pathogenesis and/or bacterial competition. At the molecular level, the T6SS could be 7 
represented as a nano-speargun [7-9] (Fig. 1A): an inner tube made of stacked Hcp hexameric 8 
rings capped by the VgrG spike complex and wrapped by a contractile sheath is propelled into 9 
the target cells during sheath contraction [10-12]. This tubular structure is assembled on a 10 
sub-membrane platform – or baseplate – that comprises the TssEFGK and VgrG subunits and 11 
is anchored to the cell envelope by the membrane complex [13-18]. 12 
 In enteroaggregagtive Escherichia coli (EAEC), the T6SS membrane core complex is 13 
constituted of the outer membrane-associated TssJ lipoprotein and the TssL and TssM inner 14 
membrane proteins [14,19,20] (Fig. 1B and C). TssJ folds as a classical transthyretin with an 15 
additional α-helix and an extended loop connecting β-strands 1 and 2 (L1-2) [21-23]. TssM 16 
comprises three transmembrane helices (TMH): TMH1 and TMH2 forms a hairpin located 17 
close to the N-terminus, separated from the third helix, TMH3, by a 35-kDa cytoplasmic 18 
domain [16,24] (Fig. 1C). The TssM cytoplasmic portion comprises two subdomains with 19 
structural homologies to NTPases and the DPY-30 dimerization hairpin [16]. The TssM 20 
cytoplasmic domain makes contact with TssL, as well as with TssG and TssK, two 21 
components of the tail assembly platform [13,15,16,18]. The majority of the EAEC TssM 22 
subunit (750 amino-acids) is located in the periplasm and its C-terminal extremity interacts 23 
with the TssJ lipoprotein L1-2 loop [14,21]. The EAEC TssL protein is a C-tail membrane 24 
protein, anchored to the inner membrane by a C-terminal TMH that requires the YidC 25 
 4 4 
insertase for its insertion [25,26] (Fig. 1C). The TssL cytoplasmic domain comprises two 3-1 
helix bundles [27-29] and interacts with two subunits of the baseplate, TssE and TssK [15,17]. 2 
In EAEC, this domain forms weak dimers, but the full-length protein (i.e., comprising the C-3 
terminal transmembrane anchor) is a stable dimer that resists Sodium Dodecyl Sulphate-Poly 4 
Acrylamide Gel Electrophoresis (SDS-PAGE; [27]).  5 
The TssJLM membrane complex is the first T6SS structure to be assembled. Its 6 
biogenesis starts with the positioning of the TssJ lipoprotein and proceeds with the sequential 7 
addition of TssM and TssL [14]. Polymerization of this hetero-trimer requires local 8 
remodelling of the cell wall layer that is assured by a dedicated peptidoglycan hydrolase or a 9 
housekeeping transglycosylase [30,31]. Ten copies of the hetero-trimer polymerize to form 10 
the 5-fold symmetry transenvelope channel. The 12-Å negative-stain electron microscopy 11 
structure of the TssJLM complex from enteroaggregative E. coli has been reported [14] (Fig. 12 
1B). It comprises a large base constituted of the cytoplasmic domains and transmembrane 13 
segments and a cap composed of TssJ. Base and cap are connected by pillars made of the 14 
TssM periplasmic domains [14]. The TssJLM structure has been obtained in a closed 15 
conformation and molecular dynamics (MD) simulations have suggested that large 16 
conformational modifications of the pillars cause opening of the structure for the passage of 17 
the inner tube during sheath contraction [14]. To resist the strength generated during sheath 18 
contraction, the TssJLM membrane complex is stably anchored to the cell wall by a 19 
peptidoglycan-binding domain either fused at the C-terminus of TssL or carried by an 20 
accessory component [20,32].  21 
Although the EM structure of the EAEC TssJLM complex and the X-ray structures of 22 
the soluble domains of TssL, TssM and TssJ have been reported, little is known on the 23 
transmembrane portion of the complex. It has been shown that the C-terminal anchor of TssL 24 
is required for T6SS function and for stable dimerization of TssL [27]. We therefore sought to 25 
 5 5 
gain insights into the structure of the TssL TMH and its dimerization determinants. TOXCAT 1 
analyses demonstrated that the TssL TMH is necessary and sufficient for dimerization. 2 
Functional assays further showed that TMH-mediated TssL dimerization is required for TssL 3 
stability and T6SS function. Finally, scanning site-directed mutagenesis coupled to TOXCAT, 4 
structural Nuclear Magnetic Resonance (NMR) studies and MD simulations defined that 5 
tryptophan rings engage in π-π interactions to mediate TssLTM dimerization.     6 
 7 
Results 8 
 9 
The TssL transmembrane segment is sufficient for dimerization. 10 
Structure-function analyses of the T6SS TssL cytoplasmic domain revealed that it 11 
weakly dimerizes [17,27]). By contrast, the full-length protein forms dimers that are stable in 12 
SDS-PAGE [27]. We concluded that the C-terminal transmembrane helix strongly contributes 13 
to TssL dimerization. To test this hypothesis, we used the TOXCAT assay [33], a two-hybrid 14 
assay based on the reconstitution of an active ToxR dimeric regulator upon association of two 15 
transmembrane helices. The dimeric ToxR regulator binds the tox promoter and activates the 16 
expression of the gene encoding chloramphenicol acetyl-transferase and conferring resistance 17 
to chloramphenicol [33,34]. The sequence corresponding to the transmembrane helix of TssL 18 
(TssLTM) was inserted between the ToxR' domain and the maltose-binding protein (MBP) to 19 
yield the ToxR'-TssLTM-MBP fusion protein. Controls include the transmembrane helix of the 20 
glycophorin A (GpA), considered as a model for transmembrane helix association, as well as 21 
a point mutant disrupting dimerization of GpA (GpAG83I) [33]. Cells producing ToxR'-22 
TssLTM-MBP grew on minimal medium with maltose as carbon source (Fig. 2A-B), 23 
demonstrating that the MBP localizes in the periplasm and hence that the construct is properly 24 
inserted in the membrane via the TssL transmembrane helix. Chloramphenicol disk and 25 
 6 6 
chloramphenicol acetyl-transferase activity (Fig. 2C and 2D) assays further showed that 1 
TssLTM dimerizes at levels comparable to the GpA control. From these data, we conclude that 2 
TssLTM dimerizes by itself in the membrane. 3 
 4 
Thr194 and Trp199 contribute to TssLTM dimerization. 5 
 To get further information on the driving forces that control TssLTM dimer formation, 6 
we used the same TOXCAT approach coupled to site directed mutagenesis screening. A 7 
number of motifs involved in transmembrane helix interactions have been reported, such as 8 
leucine zipper and GxxGxxxG motifs. Analyses of the TssLTM sequence reveals the presence 9 
of a leucine zipper motif (LxxLxxxL) comprising Leu195, Leu198 and Leu202 (shown in red 10 
in Fig. 3A). Leucine zippers are common protein-protein interaction motifs, and such a motif 11 
has been shown to be involved in the dimerization of the T4SS-associated VirB10 12 
transmembrane segment [35]. We first engineered mutations to break the TssLTM leucine 13 
zipper motif by substituting Leu195 and Leu198 by alanines (LALA variant). TOXCAT 14 
assays show that mutations of these two leucine residues had only a slight effect on the ability 15 
of TssLTM to dimerize (Fig. 3B and 3D) and thus contradict the leucine zipper hypothesis. To 16 
identify the residues of TssLTM involved in dimer formation, we performed a systematic 17 
scanning mutagenesis, in which each individual residue has been changed to tryptophan. 18 
Tryptophan side-chains are bulky and have been previously shown to disrupt contacts 19 
between tightly packed transmembrane segments [36]. Tryptophan residues of TssLTM were 20 
substituted by alanines. TOXCAT assays demonstrated that while a number of substitutions 21 
affect the stability of the TssLTM dimer, only two mutations – Thr194Trp (T194W) and 22 
Trp199Ala (W199A) — have a level of chloramphenicol acetyl transferase activity 23 
comparable to the absence of TMH (Fig. 3C and 3D).  24 
 7 7 
Previous data have shown that the TssL transmembrane helix stabilizes the TssL dimer, 1 
which then resists SDS-PAGE analysis [27]. We hence tested whether the T194W and 2 
W199A substitutions impact the stability of the TssL dimer in SDS-PAGE. As previously 3 
observed, the cytoplasmic domain of TssL (TssLC) migrates as a monomer upon SDS-PAGE 4 
whereas the dimer of the full-length TssL protein is detected (Fig. 4, lanes 1 and 2 5 
respectively). For the T194W and W199A variants of TssL only monomers are observed 6 
indicating that the T194W and W199A mutations have a strong effect on TssLTM dimer 7 
formation (Fig. 4, lanes 3 and 4). 8 
 9 
Structural analysis of the TssLTM dimer interface 10 
 To investigate the structure of the TssLTM dimer, we first conducted Nuclear Magnetic 11 
Resonance (NMR) experiments using a synthetic peptide corresponding to the TssL 12 
transmembrane segment (Met183-Ala207), stabilized by two additional lysine residues at the 13 
N- and C-termini. The TssLTM peptide was solubilized in presence of SDS because (i) the 14 
TssLTM dimer has been shown to be stable in SDS-PAGE [27], (ii) in such context, SDS 15 
micelles have been previously shown to mimick the membrane environment [37], and (iii) 16 
SDS is commonly used for solution NMR analyses of transmembrane domains [38-40]. 17 
Proton assignment of the TssLTM peptide was obtained using TOCSY and NOESY data 18 
(Table S1). On the basis of NH/NH nuclear Overhauser effect restraint measurements we 19 
concluded that the sequential NH/NH distances are in agreement with a structure of the 20 
peptide as an extended α-helix (Fig. 5A, Fig. S1) [41]. The presence of a unique set of peaks 21 
in the NMR spectra suggested that the TssL peptide forms a symmetric dimer in SDS. In this 22 
case, it is quite impossible to distinguish intra and intermolecular distance restraints (nOes) at 23 
the interface using homonuclear NMR. To investigate the dimer interface, we used hydrogen-24 
deuterium (H-D) exchange experiments by recording NOESY experiments in D2O buffer. In 25 
 8 8 
D2O the NH groups exposed to the solvent are rapidly converted in ND groups that are not 1 
observed in the proton NMR spectra. By contrast, in these conditions, the NH groups 2 
protected by a hydrogen bond or by any other contact are slowly converted in ND groups and 3 
are still observed in the proton NMR spectra. Fig. 5B and 5C show that the Trp185 and 4 
Trp199 ring NHs are significantly more protected to the solvent exchange compared to the 5 
amide groups of the rest of the TssLTM peptide, likely because of their location at the dimer 6 
interface. Thus, the H-D exchange experiments support the conclusion of the TOXCAT assay 7 
that TssLTM dimer interface involves the Trp199 rings at the periplasmic side of the TMH and 8 
in addition, provides support to the location of the Trp185 rings at the interface at the 9 
cytoplasmic side of the TMH (Fig. 5D). However, rapid H-D exchange was observed for the 10 
amide group of Thr194, suggesting that it is not protected and thus that Thr194 is not located 11 
at the dimer interface. However, although the NMR approach demonstrated that TssLTM has 12 
an helical structure and is organized as a dimer in SDS with Trp185 and Trp199 at the 13 
interface, it was not possible to define the structure of TssLTM using classical approaches of 14 
homonuclear NMR. 15 
Toward the aim to obtain a structural model of the TssLTM dimer and to better define the 16 
dimerization interface, we used molecular dynamics (MD) simulations. For comparison, these 17 
MD simulations were conducted in conditions identical to the NMR experiments (at 300K, in 18 
SDS micelle). First, a 50-ns simulation of the monomer peptide was performed in a SDS 19 
micelle containing 110 detergent molecules to generate the basic element, i.e., the TssLTM 20 
monomer. Consistent with the NMR data, the averaged structure demonstrated that the 21 
TssLTM monomer is a straight α-helix in SDS environment (Fig. 5E and 6A). This structure 22 
further shows that Trp199 and Trp185 belong to the same helix face (Fig. 5E).  By contrast, 23 
Thr194 and Trp199 belong to opposite faces (Fig. 5E and 6A), and hence, it is unlikely that 24 
both residues participate to a homodimeric interaction without substantial structure 25 
 9 9 
disturbance. To explore if such distortions could arise in the context of the dimeric structure, 1 
we performed MD simulations of TssLTM in the SDS micelle (i.e., in conditions similar to the 2 
NMR and SDS-PAGE experiments, in which the TssLTM dimer was observed). Starting from 3 
eight different symmetric conformations (see methods), the superimposition of the eight 4 
averaged structures (Fig. 6A) shows no significant changes of the structure of TssLTM. Fig. 5 
6B and 6C capture the proximity between the Thr194 or Trp199 in each dimer during the 6 
course of the 8 simulations (numbered from 0° to 350° according to the relative orientation of 7 
the helix faces). Interestingly, only the 250° simulation allows a tight proximity between the 8 
Thr194 of the two monomers (Fig. 6B), whereas the 0°, 50° and 350° simulations bring the 9 
Trp199 of both monomers at close proximity (Fig. 6C). These simulations also indicate that 10 
the Trp199 of one monomer is never close to the Thr194 residue of the other monomer. As 11 
suggested by the organization of residues on the face of the straight α-helix (Fig. 5E), the 12 
positioning of Trp199 at the interface also bring aromatic residues of the TssLTM N-terminal 13 
region (Tyr184, Trp185, Trp188) in close proximity. To further address the role of the  14 
aromatic residues at the interface, the '0' and 350° simulations were prolonged for 100 ns (Fig. 15 
6D and 6E). The two simulations converged to a very similar structure in which eight 16 
aromatic rings (Tyr184, Trp185, Trp188, Trp199 from each monomer) interact at the interface 17 
of the TMH dimer (Fig. 5F). Interestingly, Trp185 was protected in NMR H-D exchange 18 
experiments and thus described as an interfacial residue. Hence, modeling of the TssLTM 19 
dimer confirms that (i) Thr194 and Trp199 are not located on the same interface, and (ii) that 20 
Trp199 likely contributes, as well as residues Tyr184, Trp185 and Trp188, to TssLTM 21 
dimerization (Fig. 5F). The implication of Trp199 to TssLTM dimerization during MD 22 
simulations validates the results of the TOXCAT assay and NMR H-D exchange experiments.  23 
By contrast to the TOXCAT assay, the NMR and MD data did not highlight a role for residue 24 
Thr194. To test whether the replacement of Thr194 by a Trp residue interfere with TssLTM 25 
 10 1
0 
dimerization, we performed MD simulations using the TssLTM peptide bearing a Trp at 1 
position 194 (Fig. S2). This substitution significantly affects the contact map calculated for 2 
the TssLTM dimer during a 50-ns simulation. Notably, the contacts that initially involved the 3 
N-terminal aromatic cluster decrease (see for example Trp188) to the advantage of new 4 
contacts that are formed on the C-terminal region of the peptide (Fig. S2A). From the initial 5 
position (in red), this drift leads to a more open conformation (in blue) that moves forward the 6 
two N-terminal extremities (Fig. S2B). This structural change corresponds to a huge rise in 7 
the root-mean square deviation (rmsd) of monomer B relative to monomer A, that reaches a 8 
plateau at ~5-6 Å in less than 5 ns, increasing to 10 Å after 20 ns, a behavior typical of a loss 9 
of structural stability (Fig. S2C). Hence, the lack of interaction between TssLTM T194W 10 
variants in the TOXCAT assay might be correlated to a significant impairment of the TssLTM 11 
dimer integrity that could arise from subtle conformational or dynamic alterations. 12 
 13 
Transmembrane-mediated TssL dimerization is required for T6SS function. 14 
The T6SS assembles a tail-like structure comprising the tail tube made of Hcp hexameric 15 
rings wrapped by the sheath. Contraction of the sheath is proposed to propel the Hcp tube 16 
toward the target cell. The presence of the Hcp protein in the culture supernatant is therefore a 17 
reporter of T6SS activity [42]. Indeed, Hcp is detected in the culture supernatant of a wild-18 
type strain, whereas is absent in the culture supernatant of a ∆tssL mutant strain (Fig. 7A). 19 
The production of a plasmid-borne full-length TssL protein restores the release of Hcp. By 20 
contrast, despite the observation that the W199A variant is produced at levels comparable to 21 
wild-type TssL, this mutation abolishes Hcp release (Fig. 7A). The EAEC T6SS has anti-22 
bacterial activity and has been shown to provide a competitive advantage against E. coli K-12 23 
cells [43]. The results of the competition assays showed that cells producing the W199A TssL 24 
mutant are unable to eliminate competitor E. coli K-12 cells (Fig. 7B).  25 
 11 1
1 
Taken together, the Hcp release and anti-bacterial competition assays demonstrate that 1 
the TssL W199A mutation prevents proper function of the Type VI secretion apparatus in 2 
EAEC, suggesting that T6SS function requires dimerization of the TssL transmembrane 3 
anchor. 4 
 5 
TssL dimerization increases TssL stability. 6 
 To gain further insights onto the role of TssLTM dimerization during T6SS assembly, 7 
we tested whether disrupting TssLTM dimer formation impact the stability of the full-length 8 
TssL. EAEC cells producing TssL or TssL-W199A were subjected to protein synthesis arrest 9 
using the ribosomal 30S-specific spectinomycin antibiotic, and steady-state TssL levels were 10 
monitored over time. Fig. 8 shows that TssL is a rather stable protein with a half-life of ∼ 50 11 
min. The W199A substitution causes an important decrease of TssL stability, with a measured 12 
half-time < 10 min.  13 
 14 
Ligand-induced dimerization of TssL 15 
Our in vivo results, monitored in the context of the fully assembled T6SS, cannot exclude that 16 
the W199A substitution affects other functions or interactions in addition to TssLTM 17 
dimerization. We hence engineered TssL variants in which the genetically modified FK506-18 
binding protein (FKBP), FV, was fused to W199A TssL (Fig. 9A). FKBP are soluble signaling 19 
proteins that dimerize in response to a chemical inducer, rapamycin [44]. Hence, the couple 20 
FV and AP20187, a non-toxic analogue of rapamycin, could be used for ligand-induced 21 
dimerization [44,45] (Fig. 9A). FV was fused to the TssL C-terminus (Fig. 9A), which is 22 
located in the periplasm and permissive to insertion, as TssL subunits fused to peptidoglycan-23 
binding motifs are commonly found associated with T6SS [32]. TOXCAT assay showed that 24 
the presence of AP20187 in the medium overcomes the dimerization defect caused by the 25 
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2 
TssLTM W199A mutation (Fig. 9B). Ligand-induced dimerization of the TssL W199A variant 1 
restores T6SS-mediated Hcp release (Fig. 9C) and antibacterial activity (Fig. 9D), and 2 
increases TssL W199A stability to wild-type levels (Fig. 9E-G). Taken together, these results 3 
demonstrate that Trp199 is a key residue for TssLTM dimerization and that TssLTM 4 
dimerization is essential for T6SS activity. 5 
  6 
Discussion 7 
In this study, we report that the TssL transmembrane segment is a major determinant 8 
of TssL dimerization. Using a combination of TOXCAT, NMR and MD assays, we show that 9 
TssLTM dimer formation is mediated by π-π interactions involving three aromatic residues at 10 
the cytoplasmic side (Tyr184, Trp185 and Trp188) and one tryptophan at the periplasmic side 11 
(Trp199). We further provide evidence for a critical role of TM-mediated TssL dimerization 12 
in T6SS stability and activity. 13 
Few data are available in the field of bacterial secretion systems regarding the role of 14 
TM segments, and more specifically how interactions between TM helices participate to the 15 
assembly of these multiprotein complexes. However, the dimerization of the Agrobacterium 16 
tumefaciens VirB10 protein TM helix is required for Type IV secretion [35,46].  17 
Our results highlighted the specific and important role of TssLTM aromatic residues in 18 
dimer formation. Interestingly, TssLTM dimerization is mediated by a total of eight aromatic 19 
rings, with six of them forming a tight patch. π-π packing of aromatic rings is a common 20 
interaction motif in proteins [47,48], but is also a very common interface between proteins 21 
and ligands [49]. The involvement of aromatic-aromatic interactions in TM helices is not well 22 
documented [50]. By contrast, cation-π interactions, such as Lys-Trp interactions, have been 23 
shown to control TM interactions within the chloride intracellular channel protein 1 (CLIC1) 24 
[51]. Rather, tryptophan side-chains in TMH have usually functional roles including 25 
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3 
selectivity or gatekeepers such as in conjugation coupling proteins [52] and proton or 1 
potassium channels [53-56], and locks for rotameric switches, such as for the ghrelin receptor 2 
[57]. Interestingly, an alignment of the TMH sequences of T6SS-associated TssL homologues 3 
covering the different T6SS subfamilies shows that tryptophan or aromatic residues are highly 4 
conserved at the N- and C-termini of the TMHs (Fig. 10). This conservation is also shared 5 
with T4bSS-associated IcmH/DotU proteins (Fig. 10), highlighting the importance of 6 
aromatic rings at these positions. It is noteworthy that, by contrast to the EAEC TssL TMH, 7 
only one aromatic residue is usually conserved at the N-terminus. This observation suggests 8 
that the packing between two aromatic rings might be sufficient to stabilize TssL TMH 9 
formation at the N-terminus, and thus may explain why single substitution of the Y184, W185 10 
or W188 residue does not significantly impact dimer formation in the TOXCAT assay. 11 
It is worthy to note that NMR H-D experiments did not fully copy the results of the 12 
TOXCAT assay. However, the MD simulations provided molecular explanations for all the 13 
discrepancies. First, no role of residue Thr194 in TssLTM dimerization could be inferred by H-14 
D experiments, whereas the T194W substitution strongly interferes with dimerization using 15 
TOXCAT. However, MD simulations using a peptide corresponding to the T194W variant 16 
showed that this substitution induces a destabilization of the TssLTM dimer packing and a 17 
significant motion of one monomer relative to the other. Interestingly, the threonine side-18 
chain tends to bend α-helices by the formation of an additional hydrogen bond between its 19 
side-chain γO atom and the i-3 or i-4 peptide carboxyl oxygen [58]. This additional hydrogen 20 
bond also alters the dynamic of the helix bending [59] in a way that, in the TssLTM peptide, 21 
opposes to the formation of a coiled-coil on the dimerization face. Hence, incorporating a 22 
small disturbance in bending flexibility at one side of the TMH results in a significant 23 
displacement of the residues located at the other side [58], such as we observed in the case of 24 
the TssLTM dimer. In conclusion, although Thr194 does not participate directly to the TssLTM 25 
 14 1
4 
interface, the additional hydrogen bond contributed by the side-chain is important to maintain 1 
the TssLTM in a conformation competent for dimerization. The quantitative TOX-CAT assays 2 
also indicated that several substitutions along the helix affect TssLTM dimer formation, albeit 3 
to a lower extent compared to T194W. While we did not conduct MD simulations for each 4 
variant, it is likely that these substitutions slightly impact TssLTM stability and/or 5 
conformation, and thus indirectly affect its dimerization. Second, the packing of the six 6 
aromatic rings (Tyr184, Trp185 and Trp188) at the N-terminal portion of the TssL α-helix is 7 
an important determinant of TssLTM dimerization, but none of the Y184W, W185A and 8 
W188A substitutions affects dimerization by TOXCAT. As noted above, the lack of effect of 9 
these single substitutions on TOXCAT can be explained by the redundancy of the π-π 10 
interactions between these aromatic rings, an hypothesis in agreement with the observation 11 
that only one aromatic residue is usually conserved at the TssLTM N-termini. 12 
In between the N-terminal Tyr184, Trp185 and Trp188 and the C-terminal Trp199 13 
residues of the dimer interface are located the three leucine residues ascertained as a potential 14 
leucine zipper. However, the TOXCAT assay showed that mutation of this potential leucine 15 
zipper did not impact TssLTM dimerization. Interestingly, contrarily to the prototypical motif 16 
found in the CGN4 leucine zipper [60], the structure of the TssLTM peptide revealed that it 17 
does not present a coiled-coil structure. As a consequence, the leucine side-chains point 18 
toward different directions and hence there is room to accommodate Trp substitutions owing 19 
to Trp flexibility due to the free rotation along the Cα-Cβ and Cβ-Cγ bonds.   20 
The development of TssL-FV fusions to control TssL dimer levels and hence T6SS 21 
assembly is a remarkable tool. Because the assembly of the TssJLM membrane complex 22 
represents an early stage of T6SS biogenesis [13,14,61], the ligand-inducible TssL 23 
dimerization could be used to synchronize T6SS assembly and activities.  24 
 15 1
5 
Finally, a better understanding of the interactions between the TssL TMH provides the 1 
basis for the development of synthetic peptides that would inhibit TssL dimerization and thus 2 
T6SS assembly. Hydrophobic peptides interfering with transmembrane domains have been 3 
used to block the action of neuropilin-1, an actor of the human Hedgehog signalling pathway 4 
that is involved in development disorders and cancers [62,63]. TssLTM-targeting peptides that 5 
mimick the dimerization interface might be of specific interest to diminish the virulence or the 6 
anti-bacterial activity of important bacterial pathogens that use the T6SS to colonize the host, 7 
such as Vibrio cholerae, Pseudomonas aeruginosa, or Salmonella enterica [64-68].  8 
 9 
Material and Methods 10 
 11 
Bacterial strains, media, growth conditions and chemicals 12 
The bacterial strains used in this study are listed in Table S2. Escherichia coli K-12 DH5α, W3110 13 
and NT326 [69] were used for cloning procedures, anti-bacterial competition and TOXCAT assays, 14 
respectively. The enteroaggregative E. coli strain 17-2 and its ΔtssL (previously described as ΔsciP; 15 
[20]) derivative were used for this study. Strains were routinely grown in LB at 37°C with aeration. 16 
The TOXCAT assay was performed in M9 minimal medium with glucose or maltose as carbon source. 17 
Expression of the T6SS gene cluster was induced in Sci1-inducing medium (SIM; M9 minimal 18 
medium supplemented with LB 10%, glycerol 0.4%, casaminoacids 40 µg.mL-1, MgCl2 2 mM, CaCl2 19 
0.1 mM, Vitamin B1 200 µg.mL-1 [70]). Plasmids and mutations were maintained by the addition of 20 
ampicillin (100 µg.mL-1 for E. coli K-12, 200 µg.mL-1 for EAEC) or kanamycin (50 µg.mL-1 for E. 21 
coli K-12). Protein synthesis was arrested by addition of spectinomycin (200 µg.mL-1). Induction of 22 
genes cloned into pIBA vectors was obtained with anhydrotetracyclin (AHT – used at 0.02 µg.mL-1 23 
throughout the study; IBA Technologies). The AP20187 dimerization inducer was purchased from 24 
Clinisciences and used at 20 mM. The anti-TolB polyclonal antibodies are from the laboratory 25 
collection while the anti-FLAG (clone M2, Sigma Aldrich) and anti-HA (clone HA-7, Sigma-Aldrich) 26 
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monoclonal antibodies and the goat secondary anti-mouse antibodies coupled to alkaline phosphatase 1 
(Jackson Immuno) or AlexaFluor® 680 (Molecular Probes) are commercially available.   2 
 3 
Plasmid construction 4 
The plasmids used in this study are listed in Table S2. Polymerase Chain Reactions (PCR) were 5 
performed with a Biometra thermocycler, using the Pfu Turbo DNA polymerase (Stratagene). Custom 6 
oligonucleotides were synthesized by Sigma-Aldrich and are listed in Table S2. Plasmids pIBA-TssL 7 
and pIBA-TssLC producing the full-length and the cytoplasmic domain (residues 1-183) of TssL 8 
protein fused to a N-terminal FLAG sequence have been previously described [25]. The sequence 9 
encoding the TssL transmembrane helix has been inserted into the pcckan vector [69] after PCR-10 
amplification from the EAEC 17-2 chromosome DNA using primers 5-TssLTM-NheI and 3-TssLTM-11 
BamHI. The NheI-BamHI fragment was then inserted into pcckan digested by the same restriction 12 
enzymes to yield pcc-TssL-TM. FK506-binding protein (FKBP) fusion chimeras were engineered by a 13 
double PCR technique, allowing amplification of the FKBP(F36V) sequence (from plasmid 14 
pPSV35CV-ppkA-Fv; [45]) flanked by extensions annealing to the target vector [20,71]. The product 15 
of the first PCR has then been used as oligonucleotides for a second PCR using the pIBA-TssL or pcc-16 
TssL-TM as template. Site-directed mutagenesis was performed using complementary 17 
oligonucleotides bearing the desired substitutions. All constructs have been verified by colony PCR, 18 
restriction analyses and DNA sequencing (Genome Express). 19 
 20 
Antibacterial competition assay 21 
The antibacterial growth competition assay was performed as previously described [43]. Briefly, the 22 
wild-type E. coli strain W3110 bearing the pUA66-rrnB plasmid (KanR [72]) was used as prey in the 23 
competition assay. The pUA66-rrnB plasmid provides a strong constitutive green fluorescent (GFP+) 24 
phenotype. Attacker and prey cells were grown for 16 h in SIM medium, and then diluted in SIM to 25 
allow maximal expression of the sci1 gene cluster [70]. Once the culture reached an absorbance at 26 
λ=600 nm (A600) of 0.8, cells were harvested and normalized to A600=10 in SIM. Attacker and prey 27 
cells were mixed to a 4:1 ratio and 20-µL drops of the mixture were spotted in triplicate onto a pre-28 
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warmed dry SIM agar plate supplemented with 0.02 µg.mL-1 of AHT. After 4-hour incubation at 37°C, 1 
fluorescent images were recorded with a LI-COR Odyssey imager. The bacterial spots were scratched 2 
off, and cells were resuspended in LB medium and normalized to an A600=0.5. Triplicates of 200 µL 3 
were transferred into wells of a black 96-well plate (Greiner) and the A600 and fluorescence (excitation, 4 
485 nm; emission, 530 nm) were measured with a Tecan Infinite M200 microplate reader. The relative 5 
fluorescence was expressed as the intensity of fluorescence divided by the A600, after subtracting the 6 
values of a blank sample. For estimating bacterial prey survival, colony-forming units (cfu) were 7 
enumerated after plating serial dilutions on LB plates supplemented with kanamycin. The experiments 8 
were done in triplicate, with identical results, and we report here the results of a representative 9 
experiment. 10 
 11 
Hcp release assay 12 
Supernatant and cell fractions have been separated as previously described [20] except that cells were 13 
grown in SIM medium. When necessary, AHT was added 30 minutes before harvesting the cells. 14 
Briefly, 2×109 cells producing HA epitope-tagged Hcp (from plasmid pOK-HcpHA; [20]) were 15 
harvested and collected by centrifugation at 2,000 × g for 5 min. The supernatant fraction was then 16 
subjected to a second low-speed centrifugation, a high-speed centrifugation (16,000 × g for 15 min) 17 
and filtered on sterile polyester membranes with a pore size of 0.2 µm (membrex 25 PET, 18 
membraPure GmbH) before precipitation with trichloroacetic acid (TCA) 15%. Cells and precipitated 19 
supernatant were resuspended in loading buffer and analysed by SDS-PAGE and immunoblotting with 20 
the anti-HA antibody. As control for cell lysis, Western blots were probed with antibodies raised 21 
against the periplasmic TolB protein. 22 
 23 
TOXCAT assay 24 
The TOXCAT assay was performed as described [33,34,69]. MalE complementation assay: NT326 25 
cells producing the TOXCAT fusion were streaked onto M9 minimal medium plates supplemented 26 
with 0.4% glucose or with 0.4% maltose as the sole carbon source. Plates were incubated for 2 days at 27 
37°C. Disk diffusion assay: 20 µL of chloramphenicol (90 mg.mL-1) was added on a nitrocellulose 10-28 
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mm filter disk (Bio-Rad, 0.2 µm pore size) disposed onto a sterile empty petri dish. After drying, the 1 
filter was deposited at the center of a dried LB plate supplemented with ampicillin. Plates were 2 
incubated for 6 hours at 37°C before removing the filter disk. 2 mL of a culture of NT326 cells 3 
producing the TOXCAT fusion were used to make a lawn and plates were incubated ON at 37°C. The 4 
experiments have been performed in triplicate. TOXCAT quantitative assay: NT326 cells producing 5 
the TOXCAT fusion were inoculated into 10 mL of LB supplemented with ampicillin and grown to an 6 
A600=1 at 37°C with vigorous shaking. 1010 cells (~ 6 A600 units) were harvested by centrifugation and 7 
washed with 1 mL of sonication buffer (25 mM Tris-HCl, 2 mM EDTA, pH8.0). Cells were then 8 
resuspended in 1 mL of sonication buffer and lysed by sonication. CAT activity measurements: 12 µL 9 
of lysate were mixed with 300 µL of reaction buffer (0.1 mM acetyl-CoA, 0.4 mg.mL-1 5,5’-dithiobis- 10 
(2-nitrobenzoic acid), 0.1 M Tris-HCl, pH7.8), and the absorbance was acquired at λ=412 nm at 10-11 
sec intervals for a minimum of 4 min to measure the background rate of acetyl-CoA hydrolysis. Then, 12 
12 µL of 2.5 mM chloramphenicol was added, and the absorbance was measured every 10 sec. for 1 13 
min. Each lysate was assayed in triplicate, and the slopes of the recorded graphs were converted to 14 
enzyme activity units (ε= 13,600 at λ=412 nm). 15 
 16 
AP20187-mediated FK506-binding protein dimerization 17 
Dimerization of FKBP(F36V) was induced by the addition of 20 mM AP20187 (Clinisciences, 18 
resuspended in dimethylsulfoxide) in the culture medium. 19 
 20 
Protein stability assay 21 
Cultures were grown at 37°C to an A600 = 0.8, and 200 µg.mL-1 of spectinomycin was added to stop 22 
protein synthesis [73]. A sample was harvested at time zero and equivalent samples were harvested 5, 23 
10, 15, 30, 60, 120, 240 and 480 min. after spectinomycin addition. The bacterial density was 24 
measured at different time points to verify that no growth occurred. Cell pellets were resuspended in 25 
Laemmli loading buffer, heated for 15 min at 96°C, and subjected to 12.5% SDS-PAGE. Western-26 
blotting was performed with goat secondary anti-mouse antibodies coupled to AlexaFluor® 680 and 27 
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images were recorded at λ=700 nm using an LI-COR Odyssey imager. Image analyses were 1 
performed with the ImageJ processing program using the Fiji interface [74]. The image was first 2 
converted to grayscale in .jpg format. The rectangle tool of ImageJ was used to select a rectangular 3 
area of the size corresponding to the lane width, in order to cover the minimal area to contain the 4 
whole of the largest band. The same frame was used to select each TssL band of the nitrocellulose 5 
membrane. For each selection, the number of pixels was calculated. A control region with no band 6 
was also selected to subtract the background. The number of pixels of each band, relative to time 0 7 
was then plotted against time. The degradation rate constant (k) was calculated as the slope of the 8 
linear curve obtained by plotting the Napierian logarithm of each intensity value against time and 9 
fitting to a first-order decay function. Half-life values (τ½) were obtained using the equation τ½= 10 
ln(2)/k. 11 
 12 
TssLTM peptide synthesis and structural analysis by NMR 13 
A synthetic peptide, corresponding to the TssL transmembrane segment (residues Met183-Ala207) 14 
with two additional lysine residues at the N- and C-terminus of the peptide (sequence: 15 
KKMYWLSWGAGIVTLAGLWCVLSSVLAKK) was synthesized by Schafer-N (Danemark). Two 16 
samples were prepared, one in H2O and one in D2O for proton/deuterium exchange experiments. For 17 
each sample 2 mg of peptide were solubilized in 500 µL of D25-Sodium Dodecyl Sulfate 1%, in 10 18 
mM KH2PO4, 1 mM D10-Dithiothreitol, pH 4.5. TOCSY and NOESY experiments were recorded at 19 
300 K using a Bruker Avance III 600 spectrometer equipped with a TCI cryoprobe. Mixing time for 20 
the NOESY experiments was 300 ms. The NMR spectra were processed with Topsin software (Bruker) 21 
and proton assignment was obtained using the CARA software [75]. 22 
 23 
Molecular dynamics simulations 24 
On the basis of NMR data, the sequence corresponding to the synthetic TssL peptide was modelled as 25 
a canonical α-helix using the Deepview software [76]. The structure was duplicated using VMD and a 26 
Tcl script was used to build 8 symmetric dimer conformations by translating and rotating monomers. 27 
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The resulting structures were in close contact and in parallel arrangements. A peptide-detergent 1 
complex was built using the Charmm-gui server [77]. The resulting micelles contained 112 SDS 2 
molecules and 17,600 water molecules. The system was neutralized using 112 Na+ and 8 Cl- ions. All 3 
the simulations were performed using Gromacs 5.1 with the Charmm 36 forcefield. For the 4 
simulations, the default protocol and MD parameters generated by Charmm-gui were conserved.  5 
Long range electrostatic forces were computed above 1.2 nm, and a switching function was used for 6 
short-range electrostatics forces between 1 and 1.2 nm. The system was minimized using the steepest 7 
descent algorithm until the maximum force converges under 1000 kJ/mol/nm. The micelle and the 8 
water environment around the peptide were relaxed using several rounds of simulations starting from 9 
constrained peptide, then relaxing forces on side-chains and finally on the main chain. The system was 10 
thermalized and equilibrated at 300 K using several rounds of simulation over 375 ps. A timestep of 1 11 
fs, with the LINCS algorithm applied to constraint bonds that involves H atoms. The temperature was 12 
controlled using a multi-coupling scheme separating the peptide and the micelle, with an isotropic 13 
Berendsen thermostat and a coupling time constant of 5 ps and 1 ps for heating and equilibration 14 
respectively. For the production, a coupling scheme with 10-ns trajectories was produced for the 15 
various systems. The simulations were filtered on the basis of MD analysis, TOXCAT and NMR data 16 
that resulted on the selection of two simulations that were extended to 100 ns. Finally, simulations of 17 
the T194W variant were started from an equilibrated conformation of the wild-type peptide. MD 18 
simulations of Thr194 variants were performed after substitution of Thr194 by Trp on the TssLTM 19 
structure using the Depview software for 20 ns respectively. 20 
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Legend to Figures 14 
Figure 1. Schematic representation of the T6SS membrane complex and TssJLM 15 
proteins. (A) Representation of the T6SS highlighting the cytoplasmic tail structure anchored 16 
to the cell envelope by the membrane complex. (B) Negative-stain electron microscopy 17 
structural model of the TssJLM membrane complex [14]. (C) Localisation, topology and 18 
structure of the TssJ outer membrane lipoprotein, and of the TssL and TssM inner membrane 19 
proteins. IM, inner membrane; OM, outer membrane.  20 
Figure 2. TssLTM dimerizes. TOXCAT assay. NT316 reporter cells producing the indicated 21 
ToxR-X-MBP fusions (empty, no TMH sequence cloned; GpATM, Glycophorin A TMH; 22 
GpATM(G83I), GpATM with G83I substitution; TssLTM, TssL TMH) were streaked on M9 23 
minimal medium supplemented with glucose (A) or maltose (B) as sole carbon source. 24 
 30 3
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Resistance to chloramphenicol (cam) conferred by the TM-mediated dimerization of the 1 
ToxR transcriptional regulator was measured by the disk assay (C, halo diameter mean ±  2 
standard deviation [SD] in mm) and quantitative chloramphenicol acetyltransferase (Cat) 3 
assay (D). The mean (value relative to the value obtained for the "empty" vector) is indicated 4 
on top on each bar.  5 
Figure 3. Thr194 and Trp199 contribute to TssLTM dimerization. (A) Sequence of the 6 
TssLTM peptide. The numbering is relative to the full-length TssL protein. The transmembrane 7 
segment is indicated by the green frame and the leucine residues participating to a putative 8 
leucine zipper are coloured red. The two leucine residues substituted in the LALA mutant 9 
ware underlined. (B) TOXCAT disk assay of the TssLTM fragment and its LALA derivative. 10 
The diameter of the halo is indicated on bottom (mean ±  SD in mm). The quantitative Cat 11 
assay measures are reported in panel D. TOXCAT disk (C) and quantitative Cat (D) assays of 12 
the TssLTM fragments bearing the indicated substitutions. The level of activity corresponding 13 
to the empty plasmid is indicated by the red dotted line. 14 
Figure 4. TM-mediated contacts stabilize TssL dimer on SDS-PAGE. 2× 108 ∆tssL cells 15 
producing FLAG-tagged full-length TssL or the indicated TssL variants (TssLC, cytoplasmic 16 
domain of TssL; T194W and W199A, substitution variants of the TM Thr194 and Trp199 17 
residues respectively) were subjected to 12.5% SDS-PAGE and immunoblotting with the 18 
monoclonal anti-FLAG antibody. The position of TssL, TssLC and TssL dimers (*) are 19 
indicated on right. Molecular weight markers are indicated on left.  20 
Figure 5. The Trp185 and Trp199 rings are protected in NMR Hydrogen-Deuterium 21 
exchange experiments. (A) Zoom-in of the HN/HN region of the NOESY spectrum of the 22 
TssLTM peptide (2 mM) at 300K. The NMR sample was in phosphate buffer pH4.5 and SDS 23 
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1% (H2O conditions). Cross peaks (nuclear Overhauser effects) corresponding to coupling 1 
between HN of residues i and i+1 are observed. The assignment is shown in Table S1 and Fig. 2 
S1. (B and C) Overlay of the NOESY spectra of the TssLTM peptide in H2O (blue) and D2O 3 
(red). HN chemical shift assignment was indicated by residues sequence numbering. In D2O, 4 
the exposed protons are exchanged with Deuterium and thus disappeared; however the 5 
protected protons are not exchanged and thus are still observable. In (B)  the regions of HN (x 6 
axis)/ HCA (y axis) correlations is shown, and in (C) HN of rings of tryptophan residues are 7 
shown.  (D) Sequence of the TssLTM peptide. The numbering is relative to the full-length 8 
TssL protein. The transmembrane segment is indicated by the green frame, and the tryptophan 9 
residues protected in H-D exchange experiments (Trp185 and Trp199) are coloured red. (E) 10 
Structural model of the TssLTM monomer in SDS micelles. The orientation of the 11 
transmembrane segment relative to the membrane is shown. Residues located at the TssLTM 12 
interface (indicated on right), as well as residue Thr194 are represented by spheres 13 
(tryptophan residues in grey, leucine zipper residues in pink). (F) Representation of the 14 
structural model of TssLTM dimer in SDS micelles obtained by MD simulations of the TssLTM 15 
monomer. The orientation of the two transmembrane segments relative to the membrane is 16 
shown. The Trp185, Trp188 and Trp199 rings are represented by spheres and pointed with 17 
arrowheads, highlighting the packing of the two Trp199 rings at the periplasmic side and of 18 
the four rings from Trp185 and Trp188 at the cytoplasmic side.  19 
Figure 6. The Trp185 and Trp199 rings control tight packing of the TssLTM dimer. (A) 20 
Superimposition of the averaged structures of TssLTM monomerA obtained from the 21 
molecular dynamic simulations of 8 different TssLTM dimers. The Thr194 and Trp199 22 
residues are shown in spheres. (B and C) For the eight simulations of the dimer, (labeled from 23 
0° to 350°), the superimposed structure of monomer A (ribbon) is represented at the center. 24 
The Thr194 and Trp199 side chains corresponding to the reference simulation (0°) are shown 25 
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in spheres. The trajectory traces of the Thr194 (B) and Trp199 (C) side chains of monomer B 1 
are shown at the periphery of the central helix. (D and E) Top panels: distances (in nm) 2 
between the two residues Y184 (black), Trp185 (red), Trp188 (green), Thr194 (blue), or 3 
Trp199 (yellow) in the dimer during 100-ns MD simulations starting from the 0° (D) and 350° 4 
(E) conformations. Bottom panels: final structures obtained after the 100-ns MD simulations 5 
starting from the 0° (D) and 350° (E) conformations. Residues are shown in spheres with the 6 
same color code than top panels. 7 
Figure 7. Trp199 is required for T6SS function. (A) Hcp release assay. The cell pellet (C) 8 
and supernatant (S) fractions from 5× 108 cells of the wild-type 17-2 or ∆tssL derivative, or 9 
∆tssL producing FLAG-tagged full-length TssL (tssL+) or the indicated TssL variants, and 10 
HA-tagged Hcp, were subjected to 12.5% SDS-PAGE and immunoblotted with anti-TolB 11 
(periplasmic leakage control, upper panel), anti-HA (to detect Hcp, middle panel) and anti-12 
FLAG (to detect TssL, lower panel) antibodies. Molecular weigh markers are indicated on the 13 
left. (B) Anti-bacterial activity. The indicated attacker strains were mixed with kanamycin 14 
resistant GFP+ prey cells and spotted on SIM medium. After incubation, the fluorescent image 15 
of the spot was recorded (middle panel) and level of surviving prey cells was estimated by 16 
measuring the fluorescence (upper graph) and by counting the number of colonies on 17 
kanamycin plates (lower graph). 18 
Figure 8. Trp199 stabilizes TssL. (A) 5× 108-cell samples of the ∆tssL strain producing 19 
FLAG-tagged full-length TssL or the indicated TssL variants were harvested at the indicated 20 
time (in min) after protein synthesis arrest and were subjected to 12.5% SDS-PAGE and 21 
immunoblotting with anti-FLAG antibody, and secondary antibody coupled to AlexaFluor 22 
680. Molecular weigh markers are indicated on the left. The relative intensity of each band 23 
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was plotted against time (B) and half-times of TssL and TssL variants (in min) were 1 
calculated from the slope of the first-order decay function (C). 2 
Figure 9. Trp199-mediated TssLTM dimerization is required for TssL stability and T6SS 3 
function. (A) Schematic representation of the TssL-W199A-FV chimera protein. The TssL 4 
full-length protein carrying the W199A substitution (schematized with the red star) was fused 5 
to the FKBP F36V variant domain (FV, green). FV dimerization could be induced by the 6 
rapamycin homologue AP20187 (AP, pink diamond). P, periplasm; C, cytoplasm. (B) 7 
TOXCAT disk (upper panel) and quantitative Cat (lower panel) assays of W199A TssLTM 8 
fused to FV (W199A-FV) in absence (-) or presence (+) of the FKBP ligand inducer AP20187 9 
(AP). (C) Hcp release assay. The cell pellet (C) and supernatant (S) fractions from 5× 108 10 
∆tssL cells producing FLAG-tagged W199A-FV and HA-tagged Hcp, grown in absence (-) or 11 
presence (+) of AP were subjected to 12.5% SDS-PAGE and immunoblotted with anti-TolB 12 
(periplasmic leakage control, upper panel), anti-HA (to detect Hcp, middle panel) and anti-13 
FLAG (to detect TssL-FV, lower panel) antibodies. Molecular weigh markers are indicated on 14 
the left. (D) Anti-bacterial activity. The ∆tssL attacker strain producing W199A-FV was 15 
mixed with kanamycin resistant GFP+ prey cells and spotted on SIM medium supplemented 16 
(+) or not (-) with AP. After incubation, the fluorescent image of the spot was recorded 17 
(middle panel) and level of surviving prey cells was estimated by measuring the fluorescence 18 
(upper graph) and by counting the number of colonies on kanamycin plates (lower graph). (E) 19 
5× 108-cell samples of the ∆tssL strain producing TssL-W199A-FV, grown in absence (-) or 20 
presence (+) of AP were harvested at the indicated time (in min) after protein synthesis arrest 21 
and were subjected to 12.5% SDS-PAGE and immunoblotting with anti-FLAG antibody, and 22 
secondary antibody coupled to AlexaFluor® 680. Molecular weigh markers are indicated on 23 
the left. The relative intensity of each TssL-FV band was plotted against time (F) and half-24 
times of W199A-FV were calculated from the slope of the first-order decay function (G). 25 
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Figure 10. Sequence alignment of the TMHs from selected TssL homologues. The 1 
sequences of the TMHs of the T6SS-associated TssL proteins and T4bSS-associated 2 
IcmH/DotU proteins from strains listed on left (phylogeny realised based on the full-length 3 
TssL/IcmH sequences using the server at www.phylogeny.fr) were aligned using Clustal W 4 
(right panel). The position of the TMH (from experimental data for EAEC [25] or identified 5 
using the TMHMM and TMPred TMH prediction servers) is underlined in green. Tryptophan 6 
and other aromatic residues located at the N- and C-termini of the TMH sequences are 7 
indicated in red and blue respectively. The residues participating in π-π packing for EAEC 8 
TssL TMH dimerization (Y184, W185, W188 and W199; this study) are underlined.  9 
10 
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Legend to Supplementary Figures 1 
Supplementary Figure S1. Assignment of the TssLTM NOESY spectrum. The HN/HN 2 
region of the NOESY spectrum of the TssLTM peptide in H2O is shown (same as Fig. 5A). 3 
The cross peak correlations are indicated by sequential numbering of the TssLTM residues. 4 
Supplementary Figure S2. Instability in the TssLTM T194W mutant. (A) Contact map for 5 
the TssLTM dimer (left) and the T194W mutant dimer (right). (B and C) Lateral (B, left panel) 6 
and top (B, right panel) views and root mean square deviation (RMSD, in Å) (C) of the 7 
orientation of monomer B relative to the fixed monomer A during the course of the 20-ns 8 
molecular dynamics simulation of the T194W mutant. 9 
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Table S1. Sequential 1H assignment of the TssLTM peptide (residues 183-207) at 300K and pH4.5 
 
Residue     HN Ha  Hb  Others 
 
Lys-2  7.62 3.70  Hg 1.03; 0.87; He 2.13 
Lys-1  8.44 3.85  Hd 1.62; Hg 1.44;0.85 
Met183  8.30 3.57 3.38; 1.60  
Tyr184  7.36 4.50 3.96; 4.18 Hd 7.49; 7.00 He 7.33; 6.90 
Trp185  8.60 4.48 3.34; 3.3 Hd 7.14 He 9.84; 7.81 Hh 6.98 Hz 7.37; 6.80 
Leu186  8.11 4.04 1.77; 1.67 Hg 1.52 Hd 0.90; 0.80  
Ser187  7.14     4.10      3.85 
Trp188  7.78 4.37 3.12; 3.29 Hd 7.18 He 9.87; 7.48 Hh 6.99 Hz 7.37; 6.80 
Gly189  8.32 3.64 
Ala190  7.88 4.13 1.33 
Gly191  8.11 3.85 
Ile192  7.71 3.99 1.75 Hg 1.59; 1.34; Hd 0.64; 0.79   
Val193  7.97 4.23 2.2           Hg 1.76 
Thr194  7.78 4.16  Hg 1.42              
Leu195  7.50 4.09 2.04    Hd 0.89; Hg 1.35  
Ala196  8.33 4.10 1.40 
Gly197  8.17 3.75 3.62 
Leu198  7.70 4.13  Hd 0.98;0.82;  Hg 2.13 
Trp199  7.45 4.18 4.02 Hd 7.16; He 9.79;7.46; Hh 6.97; Hz 7.31;6.63 
Cys200  7.99 3.98 2.18; 1.73 
Val201  8.52 4.1 1.64 Hg 1.31   
Leu202  7.98 4.15 1.81; 1.60 Hg 1.31 
Ser203     7.70 4.13 3.70    
Ser204    8.10 3.85 3.08; 3.00  
Val205  8.21 3.75  Hg 1.6 
Leu206  8.29 3.86 1.85; 1.61    Hg 1.38  
Ala207  7.69 4.13 0.98 
Lys+1  7.67 4.26 1.69 Hd 0.98; He 2.12 
Lys+2  7.16     4.67 1.60         He 2.89 
   
 
Supplementary Table S2. Strains, plasmids and oligonucleotides used in this study. 
 
 
Strains 
 
Strains    Description and genotype                  Source 
 
E. coli K-12 
 
DH5α     F-, Δ(argF-lac)U169, phoA, supE44, Δ(lacZ)M15, relA, endA, thi, hsdR           New England Biolabs 
W3110 F-, lambda- IN(rrnD-rrnE)1 rph-1                Laboratory collection 
NT326     F-, Δ(argF-lac)U169, rpsL, relA, rbsR, flbB, ptsF,thi, deoC, ΔmalE444, recA                   [68] 
 
Enteroaggregative E. coli 
 
17-2     WT enteroaggregative Escherichia coli      Arlette Darfeuille-Michaud 
17-2ΔtssL    17-2 deleted of the tssL gene of the sci1 T6SS gene cluster                 [20] 
 
 
 
Plasmids 
 
Vectors    Description                       Source 
 
Expression vectors  
 
pASK-IBA37    cloning vector, Ptet, AmpR              IBA Technology  
pASK-IBA37-TssLFL   sci1 tssL cloned into pASK-IBA37, C-terminal FLAG epitope                                              [25] 
pASK-IBA37-TssLC                Cytoplasmic domain (residues 1-183) of sci1 tssL cloned into pASK-IBA37,  
         N-terminal FLAG epitope                                                                     [25] 
pASK-IBA37-TssLFL-T194W Thr194 to Trp into pASK-IBA37-TssLFL                                                        This study 
pASK-IBA37-TssLFL-W199A Trp199 to Ala into pASK-IBA37-TssLFL                                                        This study 
pASK-IBA37-TssLFL-W199A-FK FK506 binding protein fused to TssL into pASK-IBA37-TssLFL                                  This study 
pOK-HcpHA    sci1 hcp cloned into pOK12, C-terminal HA epitope                             [20] 
pUA66-rrnb     PrrnB ::gfpmut2 transcriptional fusion in pUA66, KanR                       [71] 
 
Vectors for TOXCAT assay 
 
pcckan     ToxR-dependent expression of cat                   [33] 
pccGpA    pcckan plasmid with glycophorin A TMH inserted between ToxR and MBP             [33] 
pccGpG83I    Gly83 to Ile into pccGpA                       [33] 
pcc-TssL-TM    pcckan plasmid with TssL TMH (residues 174-217) inserted between ToxR and MBP               This study 
pcc-TssL-LALA   Leu-195 and Leu-198 to Ala into pcc-TssL-TM                 This study 
pcc-TssL-M183W   Met-183 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-Y184W   Tyr-183 to Trp into pcc-TssL-TM                        This study 
pcc-TssL-W185A   Trp-185 to Ala into pcc-TssL-TM                       This study 
pcc-TssL-L186W   Leu-186 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-S187W   Ser-187 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-W188A   Trp-188 to Ala into pcc-TssL-TM                       This study 
pcc-TssL-G189W   Gly-189 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-A190W   Ala-190 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-G191W   Gly-191 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-I192 W   Ile-192 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-V193W   Val-193 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-T194W   Thr-194 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-L195W   Leu-195 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-A196W   Ala-196 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-G197W   Gly-197 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-L198W   Leu-198 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-W199A   Trp-199 to Ala into pcc-TssL-TM                       This study 
pcc-TssL-C200W   Cys-200 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-V201W   Val-201 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-L202W   Leu-202 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-S203W   Ser-203 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-S204W   Ser-204 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-V205W   Val-205 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-L206W   Leu-206 to Trp into pcc-TssL-TM                       This study 
pcc-TssL-W199A-FK  FK506 binding protein fused to TssL-TM into pcc-TssL-W199                 This study 
 
 
 
Oligonucleotides 
 
Name    Destination    Sequence (5’ ! 3’) 
 
For plasmid construction 
 
5-TssLTM-NheI   insertion of TssL-TM into pcckan   GGTGGTGGTGCGTGCTAGCGCACCGGGTTACCGTG 
3-TssLTM-BamHI   insertion of TssL-TM into pcckan            CGTACGTGCATGGTTAGGATCCCTCCCTGCCCGGTA 
AGCC 
5-pcckn-L-TM-FKBP  FK506 binding protein fused to TssL-TM CAGGTGGCACGGCTTACCGGGCAGGGAGGGCTC 
                            GAGATGGCTTCTAGAGGAGTGCAGGTG             
3-pcckn-L-TM-FKBP  FK506 binding protein fused to TssL-TM GTTTAAAGCTGGATTGGCTTGGGTTGATCAGGA 
                        TTCATTCCAGTTTTAGAACCTTCACATCG 
5-IBA-TssL-LFKBP   FK506 binding protein fused to TssL CAGGTGGCACGGCTTACCGGGCAGGGACTCGAGATGG 
             CTTCTAGAGGAGTGCAGG 
3-IBA-TssL-FKBP   FK506 binding protein fused to TssL GATGGTGATGCGATCCTCTGCTAGCTCATTCCAGTTTT 
AGAACCTTCACATCGAAG 
 
For site directed mutagenesis 
 
5-TssL-L195A-L198A  Leu195 to Ala and Leu198 to Ala  GGGGCGGGTATTGTGACGGCGGCTGGTGCCTGGTGTG 
                            TGCTTTCTTC 
3-TssL-L195A-L198A  Leu195 to Ala and Leu198 to Ala  GAAGAAAGCACACACCAGGCACCAGCCGCCGTCACAA 
TACCCGCCCC 
5-A-M183W    Met183 to Trp     GTTACCGTGCTGGCAGAACGTGGTACTGGTTGTCATGG 
                                                                                                                                   GGG              
5-A-Y184W    Tyr183 to Trp     GTTACCGTGCTGGCAGAACGATGTGGTGGTTGTCAT 
                       GGGGGGCG 
5-A-W185A    Trp185 to Ala                    GTTACCGTGCTGGCAGAACGATGTACGCGTTGTCATG 
                                                                                                                                   GGGGGCGGG 
5-A-L186W    Leu186 to Trp     GTTACCGTGCTGGCAGAACGATGTACTGGTGGTCAT 
 GGGGGGCGGGTAT 
5-A-S187W    Ser187 to Trp     GTTACCGTGCTGGCAGAACGATGTACTGGTTGTGGTG 
                                                                                                                                   GGGGGCGGGTATTGTG 
3-A-M183-S187         TCTGCCAGCACGGTAACCCGGTGCACGCAC 
5-B-W188A    Trp188 to Ala     GAACGATGTACTGGTTGTCAGCGGGGGCGGGTATTGT 
                   GAC 
5-B-G189W    Gly189 to Trp     GAACGATGTACTGGTTGTCATGGTGGGCGGGTATTGTG 
ACG 
5-B-A190W    Ala190 to Trp     GAACGATGTACTGGTTGTCATGGGGGTGGGGTATTGT 
             GACGCT 
5-B-G191W    Gly191 to Trp     GAACGATGTACTGGTTGTCATGGGGGGCGTGGATTGT 
GACGCTGGC 
5-B-I192W    Ile192 to Trp     GAACGATGTACTGGTTGTCATGGGGGGCGGGTTGGGT 
             GACGCTGGCTGG 
3-B-W188-I192         CAACCAGTACATCGTTCTGCCAGCACGGTA 
5-C-V193W    Val193 to Trp     TGTCATGGGGGGCGGGTATTTGGACGCTGGCTGGTCTC 
             TGG 
5-C-T194W    Thr194 to Trp     TGTCATGGGGGGCGGGTATTGTGTGGCTGGCTGGTCTC 
             TGGTG 
5-C-L195W    Leu195 to Trp     TGTCATGGGGGGCGGGTATTGTGACGTGGGCTGGTCTC 
             TGGTGTG 
5-C-A196W    Ala196 to Trp     TGTCATGGGGGGCGGGTATTGTGACGCTGTGGGGTCTC 
             TGGTGTGTG 
5-C-G197W    Gly197 to Trp     TGTCATGGGGGGCGGGTATTGTGACGCTGGCTTGGCTC 
TGGTGTGTGCTT 
3-C-V193-G197         ACCCGCCCCCCATGACAACCAGTACATCGT  
5-D-L198W    Leu198 to Trp     GTATTGTGACGCTGGCTGGTTGGTGGTGTGTGCTTTCT 
TCT 
5-D-W199A    Trp199 to Ala     GTATTGTGACGCTGGCTGGTCTCGCGTGTGTGCTTTCT 
             TCTGTG 
5-D-C200W    Cys200 to Trp     GTATTGTGACGCTGGCTGGTCTCTGGTGGGTGCTTTCT 
TCTGTGCT 
5-D-V201W    Val201 to Trp     GTATTGTGACGCTGGCTGGTCTCTGGTGTTGGCTTTCTT 
              CTGTGCTTGC 
5-D-L202W    Leu202 to Trp     GTATTGTGACGCTGGCTGGTCTCTGGTGTGTGTGGTCT 
             TCTGTGCTTGCAG 
3-D-L198-L202         AGCCAGCGTCACAATACCCGCCCCCCATGA 
5-E-S203W    Ser203 to Trp     CTGGTCTCTGGTGTGTGCTTTGGTCTGTGCTTGCAGAC 
CAG  
5-E-S204W    Ser204 to Trp      CTGGTCTCTGGTGTGTGCTTTCTTGGGTGCTTGCAGAC 
              CAGGTG 
5-E-V205W    Val205 to Trp     CTGGTCTCTGGTGTGTGCTTTCTTCTTGGCTTGCAGACC 
AGGTGGCA 
5-E-L206W    Leu206 to Trp     CTGGTCTCTGGTGTGTGCTTTCTTCTGTGTGGGCAGAC 
             CAGGTGGCACG 
3-E-S203-L206         CACACACCAGAGACCAGCCAGCGTCACAAT 
 
 
 
